These results suggest that higher levels of secreted endostatin, 8-OHdG, and vimentin indicate increased risk of symptomatic CD development, while higher levels of circulating hnRNPA1 indicate lower risk of symptomatic disease in T. cruzi-infected humans. Here, HNRNPA1 is linked to Cowden disease.